New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma

NEXT STORY
Trevena to Present at the JMP Securities Life Sciences Conference
PREV STORY
Gene Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ocera Announces Top-line Results for Phase 2b Study in Hepatic Encephalopathy

Primary and Secondary Endpoints Showed Trend and Dose-Related Clinical Benefit Although Not Statistically Significant ...

author_avatar
NASDAQ Market News

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy

author_avatar
NASDAQ Market News

Genocea to Present at 29th Annual Piper Jaffray Healthcare Conference

CAMBRIDGE, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company ...

author_avatar
NASDAQ Market News